PATIENT-CENTERED GUIDES


Catalog
Patient Centers
Home
Non-Hodgkin's Lymphoma Center Home

Non-Hodgkin's Lymphoma Center
Non-Hodgkin's Lymphoma Center

Bibliography


The following excerpt is taken from the Bibliography of Non-Hodgkin's Lymphomas: Making Sense of Diagnosis, Treatment, and Options by Lorraine Johnston, copyright 1999 by O'Reilly & Associates, Inc. For book orders/information, call 1-800-998-9938. Permission is granted to print and distribute this excerpt for noncommercial use as long as the above source is included. The information in this article is meant to educate and should not be used as an alternative for professional medical care.

Chapter 1: Symptoms and Diagnosis

Altman and Sarg. The Cancer Dictionary. Facts on File, 1992.

Berkow, R., editor. The Merck Manual of Diagnosis and Therapy, 17th edition. Merck & Co., Inc., 1999.

Goleman, Daniel. Emotional Intelligence. Bantam, 1995.

Harpham, Wendy. Diagnosis: Cancer. New York: W. W. Norton, 1998.

Johnson, J., and Klein, L. I Can Cope: Staying Healthy With Cancer. Minneapolis: Chronimed, 1994.

Kubler-Ross, Elisabeth. On Death and Dying. MacMillan, 1969.

Magrath, editor. The Non-Hodgkin's Lymphomas, 2nd ed. London: Arnold and Oxford University Press, 1997.

The National Cancer Institute's PDQ State-of-the-Art Treatment Statements for Physicians on: Adult Non-Hodgkin's Lymphoma, Childhood Non-Hodgkin's Lymphoma, Breast Cancer and Pregnancy, Non-Hodgkin's lymphoma during pregnancy, AIDS-related Lymphomas, Cutaneous T-Cell Lymphoma, Primary Central Nervous System Lymphoma.

Siebert, Al. The Survivor Personality. Practical Psychology Press, 1994.

Chapter 2: Finding the Right Oncologist

Brenner and Hall. Making the Radiation Therapy Decision. RGA Publishing Group, 1996

Dollinger, M., Rosenbaum, E., and Cable, G. editors. Everyone's Guide to Cancer Therapy. Andrews & McMeel, 1994.

Murphy, G., Morris, L., and Lange, D., editors. Informed Decisions - The Complete Book of Cancer Diagnosis, Treatment and Recovery. The American Cancer Society. New York: Viking Press, 1997.

Keene, Nancy. Childhood Leukemia: A Guide for Families, Friends, and Caregivers. Sebastopol: O'Reilly & Associates, 1997.

"Best Hospitals." Annual edition. U.S. News and World Report's. Washington, DC 20037-1196; (202) 955-2000.

Chapter 3: What are the NHLs?

Amadori, D., et al. "Chronic lymphocytic leukaemias and non-Hodgkin's lymphomas by histological type in farming-animal breeding workers: a population case-control study based on job titles." Occupational and Environmental Medicine 52, no. 6 (1995): 374-79.

Crosby, Alfred W. America's Forgotten Pandemic: The Influenza of 1918. Cambridge University Press, 1989.

Blair, A., et al. "Evaluation of risks for non-Hodgkin's lymphoma by occupation and industry exposures from a case-control study." American Journal of Industrial Medicine 23, no. 2 (1993): 301-12.

Cancer Rates and Risks, 1996. The National Cancer Institute. 1-800-4-CANCER.

Chiu, B. C., et al. "Diet and risk of non-Hodgkin lymphoma in older women." Journal of the American Medical Association 275, no. 17 (1996): 1315-21.

Doody, M. M., et al. "Risks of non-Hodgkin's lymphoma, multiple myeloma, and leukemia associated with common medications." Epidemiology 7, no. 2 (1996): 131-39.

Hammond, D. W., et al. "Cytogenetic analysis of a United Kingdom series of non-Hodgkins lymphomas." Cancer, Genetics and Cytogenetics 61, no. 1 (1992): 31-38.

Hayes, R. B., et al. "Benzene and the dose-related incidence of hematologic neoplasms in China." Chinese Academy of Preventive Medicine-National Cancer Institute Benzene Study Group. Journal of the National Cancer Institute 16, no.14 (1997): 1065-71.

Jackow, C. M., et al. "Follicular mucinosis associated with scarring alopecia, oligoclonal T-cell receptor V-beta expansion, and Staphylococcus aureus: When does follicular mucinosis become mycosis fungoides?" Journal of the American Academy of Dermatology 37, no. 5 (1997): 828-31.

Kant, J. A., et al. "The pathologic and clinical heterogeneity of lymphocyte-depleted Hodgkin's disease." Clinical Oncology 4, no. 3 (1986): 284-94.

Koulis, A., et al. "Characterization of tumor-infiltrating T-lymphocytes in B-cell lymphomas of mucosa-associated lymphoid tissue." American Journal of Pathology 151, no. 5 (1997): 1353-60.

Magrath, editor. The Non-Hodgkin's Lymphomas, 2nd edition. London: Arnold and Oxford University Press, 1997.

Masala, G., et al. "Incidence rates of leukemias, lymphomas and myelomas in Italy: Geographic distribution and NHL histotypes." International Journal of Cancer 68, no. 2 (1996): 156-59.

Moses, A. V., et al. "HIV-1 induction of CD40 on endothelial cells promotes the outgrowth of AIDS-associated B-cell lymphomas." Nature Medicine 3, no. 11 (1997): 1242-49.

Nelson, R. A., et al. "Alcohol, tobacco and recreational drug use and the risk of non-Hodgkin's lymphoma." British Journal of Cancer 76, no. 11 (1997): 1532-37.

The National Cancer Institute's PDQ State-of-the-Art Treatment Statements for Physicians on: AIDS-related Lymphomas, Adult Non-Hodgkin's Lymphoma, Bone metastases, Childhood Non-Hodgkin's Lymphoma, Cutaneous T-Cell Lymphoma., Liver Metastastes, Primary Central Nervous System Lymphoma

Persson, B. "Occupational exposure and malignant lymphoma.." International Journal of Occupational Medicine and Environmental Health 9, no. 4 (1996): 309-21.

Satoh, T., et al. "The relationship between primary splenic malignant lymphoma and chronic liver disease associated with hepatitis-C virus infection." Cancer 80, no. 10 (1997): 1981-88.

Tavani, A., et al. "Diet and risk of lymphoid neoplasms and soft tissue sarcomas." Nutrition and Cancer 27, no. 3 (1997): 256-60.

Chapter 4: Prognoses

Bastion, Y., et al. "Elderly patients with aggressive non-Hodgkin's lymphoma: disease presentation, response to treatment, and survival--A Groupe d'Etude des Lymphomes de l'Adulte study on 453 patients older than 69 years." Journal of Clinical Oncology 15, no. 8 (1997): 2945-53.

Bollen, E. L., et al. "Central nervous system relapse in non-Hodgkin lymphoma. A single-center study of 532 patients." Archives of Neurology 54, no. 7 (1997): 854-59.

Bolwell, B., et al. "Durability of remission after ABMT for NHL: The importance of the 2-year evaluation point." Bone Marrow Transplantation 19, no. 5 (1997): 443-48.

Christiansen, I., et al. "Elevated serum levels of soluble ICAM-1 in non-Hodgkin's lymphomas correlate with tumour burden, disease activity and other prognostic markers." British Journal of Haematology 92, no. 3 (1996): 639-46.

Clodi, K., et al. "Analysis of p53 gene deletions in patients with non-Hodgkin's lymphoma by dual-colour fluorescence in-situ hybridization." British Journal of Haematology 98, no. 4 (1997): 913-21.

Coad, N. A., et al. "Analysis of ploidy and proliferative activity in childhood non-Hodgkin's lymphoma (NHL) and Hodgkin's disease (HD)." Pediatric Pathology and Laboratory Medicine 17, no. 6 (1997): 893-02.

Czader, M., et al. "Prognostic significance of proliferative and apoptotic fractions in lowgrade follicle center cell-derived non-Hodgkin's lymphomas." Cancer 77, no. 6 (1996): 1180-88.

d'Amore, F. A., et al. "Non-Hodgkin lymphoma in the elderly." Ugeskrift for Laeger 155, no. 56 (1993): 3754-59.

d'Amore, F. A., et al. "Epstein-Barr virus genome in non-Hodgkin's lymphomas occurring in immunocompetent patients: Highest prevalence in nonlymphoblastic T-cell lymphoma and correlation with a poor prognosis. Danish Lymphoma Study Group, LYFO." Blood 87, no. 3 (1996): 1045-55.

Dann, E. J., et al. "Allogeneic Bone marrow transplantation for relapsed and refractory Hodgkin's disease and non-Hodgkin's lymphoma." Bone Marrow Transplantation 20, no. 5(1997): 369-74.

Davidge-Pitts, M., et al. "Prolonged survival in follicular non Hodgkins lymphoma is predicted by achievement of complete remission with initial treatment: results of a long-term study with multivariate analysis of prognostic factors." Leukemia and Lymphoma 24, nos. 1-2 (1996): 131-40.

de Jong, D., et al. "Histological grading in gastric lymphoma: pretreatment criteria and clinical relevance." Gastroenterology 112, no. 5 (1997): 1466-74.

de Kreuk, M., et al. "Prognostic factors for survival of non-Hodgkin's lymphoma patients treated with high-dose chemotherapy and autologous bone marrow transplantation." Bone Marrow Transplantation 17, no. 6 (1996): 963-71.

De Nardo, G. L., et al. "Increased survival associated with radiolabeled Lym-1 therapy for non-Hodgkin's lymphoma and chronic lymphocytic leukemia." Cancer 15, no. 80 (1997): 2706-11.

Dimopoulos, M. A., et al. "Primary ovarian non-Hodgkin's lymphoma: outcome after treatment with combination chemotherapy." Gynecologic Oncology 64, 1997 Mar;64(3): 446-50.

Economopoulos, T., et al. "Primary extranodal non-Hodgkin's lymphoma in adults: Clinicopathological and survival characteristics." Leukemia and Lymphoma 21, nos. 1-2 (1996): 131-36.

Gascoyne, R. D., et al. "Prognostic significance of Bcl-2 protein expression and Bcl-2 gene rearrangement in diffuse aggressive non-Hodgkin's lymphoma." Blood 90, no. 1 (1997): 244-51.

Hahn, J. S., et al. "Eight-year experience of malignant lymphoma--survival and prognostic factors." Yonsei Medical Journal 38, no. 5 (1997): 270-84.

Heinz, R., Hopfinger, G., and Tuchler, H. "Outcome of patients with low-grade B cell non-Hodgkin lymphoma and initial bone marrow involvement: Data of a single institution." Leukemia 11, no. 2 (1997): 52-54.

Hill, M. E., et al. "Prognostic significance of BCL-2 expression and bcl-2 major breakpoint region rearrangement in diffuse large cell non-Hodgkin's lymphoma: a British National Lymphoma Investigation Study." Blood 88, no. 3 (1996): 1046-51.

Janicek, M., et al. "Early restaging gallium scans predict outcome in poor-prognosis patients with aggressive non-Hodgkin's lymphoma treated with high-dose CHOP chemotherapy." Journal of Clinical Oncology 15, no. 4 (1997): 1631-37.

Juneja, S., et al. "Prognostic value of cytogenetic abnormalities in previously untreated patients with non-Hodgkin's lymphoma." Leukemia and Lymphoma 25, nos. 5-6 (1997): 493-01.

Koduru, P. R., et al. "Correlation between mutation in P53, p53 expression, cytogenetics, histologic type, and survival in patients with B-cell non-Hodgkin's lymphoma." Blood 90, no. 10 (1997): 4078-91.

Kovner, F., et al. "Prognostic importance of advanced age in aggressive non-Hodgkin's malignant lymphoma." Oncology 53, no. 6 (1996): 435-40.

Kramer, M. H., et al. "Clinical significance of bcl2 and p53 protein expression in diffuse large B-cell lymphoma: A population-based study." Journal of Clinical Oncology 14, no. 7 (1996): 2131-38.

Krol, A. D., et al. "Gastric lymphomas compared with lymph node lymphomas in a population-based registry differ in stage distribution and dissemination patterns but not in patient survival." Cancer 79, no. 2 (1997): 390-97.

Kusnierz-Glaz, C. R., et al. "Influence of age on the outcome of 500 autologous bone marrow transplantation procedures for hematologic malignancies." Journal of Clinical Oncology 15, no. 1 (1997): 18-25.

Lazzarino, M., et al. "Treatment outcome and prognostic factors for primary mediastinal (thymic) B-cell lymphoma: A multicenter study of 106 patients." Journal of Clinical Oncology 15, no. 4 (1997): 1646-53.

Macia, J., et al. "Value of the determination of TNF-alpha in the plasma of patients with non-Hodgkins lymphoma." Leukemia and Lymphoma 20, nos. 5-6 (1996): 481-86.

Maksymiuk, A. W., et al. "Age-related prognostic factor analysis in non-Hodgkin's lymphoma." Canadian Journal of Oncology 6, no. 1 (1996): 435-42.

Mandigers, C. M., et al. "Allogeneic bone marrow transplantation with T-cell-depleted marrow grafts for patients with poor-risk relapsed low-grade non-Hodgkin's lymphoma." British Journal of Haematology 100, no. 1 (1998): 198-06.

Munksgaard, L., et al. "CB/CC diffuse lymphoma: A distinct subtype of non-Hodgkin's lymphoma? A study of 1593 patients from a Danish population-based registry. Danish LYFO Study Group." Annals of Oncology 8, no. 2 (1997): 25-28.

Muramatsu, M., et al. "Rearrangement of the BCL6 gene in B-cell lymphoid neoplasms." Leukemia 11, no. 3 (1997): 318-20.

Niitsu, N. "Prognostic factors in elderly patients with non-Hodgkin's lymphoma treated with cyclophosphamide, vincristine, prednisone, bleomycin, Adriamycin, procarbazine (COP-BLAM) therapy." Acta Haematologica 98, no. 3 (1997): 130-35.

The Non-Hodgkin's Lymphoma Classification Project. "A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma." Blood 89, no. 11 (1997): 3909-18.

Magrath, editor. The Non-Hodgkin's Lymphomas, 2nd edition. London: Arnold and Oxford University Press, 1997.

Osada, M., et al. "Mutation does not determine prognosis in non-Hodgkin's lymphoma." Gan To Kagaku Ryoho 24, no. 4 (1997): 471-75.

The National Cancer Institute's PDQ State-of-the-Art Treatment Statements for Physicians on: Adult non-Hodgkin's lymphoma, Childhood non-Hodgkin's lymphoma, Childhood acute lymphocytic leukemia, Cutaneous T-cell lymphoma, AIDS-related lymphoma.

Pittaluga, S., et al. "Clinical analysis of 670 cases in two trials of the European Organization for the Research and Treatment of Cancer Lymphoma Cooperative Group subtyped according to the Revised European-American Classification of Lymphoid Neoplasms: A comparison with the Working Formulation." Blood 87, no. 10 (1996): 4358-67.

Poley, S., et al. "Serum thymidine kinase in non-Hodgkin lymphomas with special regard to multiple myeloma." Anticancer Research 17, no. 4B (1997): 3025-29.

Prince, H. M., et al. "The role of intensive therapy and autologous blood and marrow transplantation for chemotherapy-sensitive relapsed and primary refractory non-Hodgkin's lymphoma: identification of major prognostic groups." British Journal of Haematology 92, no. 4 (1996): 880-89.

Rolland-Portal, I., et al. "Non-Hodgkin's lymphoma: time trends for incidence and survival in Cote-d'Or, France." International Journal of Epidemiology 26, no. 5 (1997): 945-52.

Sarris, A. H., et al. "Primary parotid lymphoma: the effect of International Prognostic Index on outcome." Leukemia and Lymphoma 26, nos. 1-2 (1997): 49-56.

Shiota, M., and Mori, S. "The clinicopathological features of anaplastic large cell lymphomas expressing p80 NPM/ALK." Leukemia and Lymphoma 23, nos. 1-2 (1996): 25-32.

Tsunoda, S., et al. "Clinical and prognostic significance of femoral marrow magnetic resonance imaging in patients with malignant lymphoma." Blood 89, no. 1 (1997): 286-90.

Vaccher, E., et al. "Age and serum lactate dehydrogenase level are independent prognostic factors in human immunodeficiency virus-related non-Hodgkin's lymphomas: A single-institute study of 96 patients." Journal of Clinical Oncology 14, no. 8 (1996): 2217-23.

van Besien, K., et al. "Allogeneic transplantation for recurrent or refractory non-Hodgkin's lymphoma with poor prognostic features after conditioning with thiotepa, busulfan, and cyclophosphamide: Experience in 44 consecutive patients." Biology of Blood and Marrow Transplants 3, no. 3 (1997): 150-56.

Verdonck, L. F., et al. "Allogeneic versus autologous Bone marrow transplantation for refractory and recurrent low-grade non-Hodgkin's lymphoma." Blood 90, no. 10 (1997): 4201-05.

Vose, J. M., et al. "Single-photon emission computed tomography gallium imaging versus computed tomography: Predictive value in patients undergoing high-dose chemotherapy and autologous stem-cell transplantation for non-Hodgkin's lymphoma." Journal of Clinical Oncology 14, no. 9 (1996): 2473-79.

Warzocha, K., et al. "Tumor necrosis factor ligand-receptor system can predict treatment outcome in lymphoma patients." Journal of Clinical Oncology 15, no. 2 (1997): 499-08.

Wilson, W. H., et al. "Relationship of p53, bcl-2, and tumor proliferation to clinical drug resistance in non-Hodgkin's lymphomas." Blood 89, no. 2 (1997): 601-09.

Yamada, Y., et al. "Frequent hepatic involvement in adult T cell leukemia: Comparison with non-Hodgkin's lymphoma." Leukemia and Lymphoma 26, nos. 3-4 (1997): 327-35.

Zemunik, T., et al. "Prognostic parameters in low-grade non-Hodgkin's lymphomas." Neoplasma 44, no. 1 (1997): 13-17.

Zinzani, P. L., et al. "Adult lymphoblastic lymphoma: Clinical features and prognostic factors in 53 patients." Leukemia and Lymphoma 23, nos. 5-6 (1996): 577-82.

Zinzani, P. L., et al. "Anaplastic large-cell lymphoma: Clinical and prognostic evaluation of 90 adult patients." Journal of Clinical Oncology 14, no. 3 (1996): 955-62.

Chapter 5: Tests and Procedures

Andrews, Maraca, and Shaw, Michael. Everything You Need to Know About Medical Tests. 691 pages. Springhouse, 1996. An excellent comprehensive reference written for the patient in a readable and respectful style.

The Biology Project, University of Arizona at: http://www.biology.arizona.edu

Brodin, Michael B. The Encyclopedia of Medical Tests, 592 pages, Pocket Books 1997. A 1982 book with the same title written by Pinckney and Pinckney should be passed over in favor of this newer book.

Department of Pathology, University of Washington, Seattle: http://www.pathology.washington.edu

The Family Internet site at http://familyinternet.com

HealthGate at http://www.healthgate.com

Keene, Nancy. Childhood Leukemia: A Guide for Families, Friends, and Caregivers. Sebastopol: O'Reilly & Associates, 1997.

Keene, Nancy. Your Child in the Hospital. Sebastopol: O'Reilly and Associates, 1997.

Magrath, editor. The Non-Hodgkin's Lymphomas, 2nd edition. London: Arnold and Oxford University Press, 1997.

Mid-South Imaging & Therapeutics, P.A. at http://www.msit.com

Mosby ConsumerHealth Series http://www.mosbych1.com/mhc/top/003833.htm

Pagana, Kathleen, and Pagana, Timothy, editors. Mosby's Diagnostic and Laboratory Test Reference. Mosby, 1992.

Shtasel, Philip. Medical Tests and Diagnostic Procedures - A Patient's Guide to Just What the Doctor Ordered. Harper and Row, 1990.

The Patient's Guide to Medical Tests, Barry L., ed. Zaret, Peter, Jatlow, Lee D., Houghton Mifflin Co (Trd), 1997.

Stauffer, Joseph, and Segen, Joseph C. The Patient's Guide to Medical Tests: Everything You Need to Know About the Tests Your Doctor Prescribes, 4th edition. Facts on File, 1997.

ThriveOnline http://www.thriveonline.com

University of California at Los Angeles http://anima.crump.ucla.edu

Chapter 6: How the NHLs Are Treated

Aydogdu, I., et al. "Administration of MINE protocol in untreated patients with intermediate and high grade non-Hodgkin's lymphoma." Haematologia 28, no. 4 (1997): 207-13.

Baldini, L., et al. "A pilot study on the use of the ProMACE-CytaBOM regimen as a first-line treatment of advanced follicular non-Hodgkin's lymphoma." Cancer 79, no. 6 (1997): 1234-40.

Ballestrero, A., et al. "High-dose mitoxantrone with peripheral blood progenitor cell rescue: toxicity, pharmacokinetics and implications for dosage and schedule." British Journal of Cancer 76, no. 6 (1997): 797-04.

Bellesi, G., et al. "A new protocol (MiCEP) for the treatment of intermediate or high-grade non-Hodgkin's lymphoma in the elderly." Leukemia and Lymphoma 20, nos. 5-6 (1996): 475-80.

Bird, J. M., et al. "4-Hydroperoxycyclophosphamide purged autologous bone marrow transplantation in non-Hodgkin's lymphoma patients at high risk of bone marrow involvement." Bone Marrow Transplantation 18, no. 2 (1996): 309-13.

Bolwell, B., et al. "Durability of remission after ABMT for NHL: The importance of the2-year evaluation point." Bone Marrow Transplantation 19, no. 5 (1997): 443-48.

Caballero, M. D., et al. "BEAM chemotherapy followed by autologous stem cell support in lymphoma patients: Analysis of efficacy, toxicity and prognostic factors." Bone Marrow Transplantation 20, no. 6 (1997): 451-58.

Caballero, M. D., et al. "Alternating mini-BEAM/ESHAP as salvage therapy for refractory non-Hodgkin's lymphomas." Annals of Hematology 74, no. 2 (1997): 79-82.

Cameron, D. A., et al. "CHOP-based chemotherapy is as effective as alternating PEEC/CHOP chemotherapy in a randomised trial in high-grade non-Hodgkin's lymphoma. Scotland and Newcastle Lymphoma Group." European Journal of Cancer 33, no. 8 (1997): 1195-01.

Caracciolo, F., et al. "Consolidation therapy with idarubicin, cisplatin and prednisone (CIP) after P-VABEC regimen in the treatment of intermediate and high grade non-Hodgkin's lymphoma of the elderly." Leukemia and Lymphoma 24, nos. 3-4 (1997): 355-61.

Clinical Pharmacology Online: http://www.cponline.gsm.com

Dann, E. J., Daugherty, C. K., and Larson, R. A. "Allogeneic bone marrow transplantation for relapsed and refractory Hodgkin's disease and non-Hodgkin's lymphoma." Bone Marrow Transplantation 20, no. 5 (1997): 369-74.

De Nardo, G. L., et al. "Increased survival associated with radiolabeled Lym-1 therapy for non-Hodgkin's lymphoma and chronic lymphocytic leukemia." Cancer 80, no. 12 (1997): 2706-11.

Dimopoulos, M. A., et al. "Primary ovarian non-Hodgkin's lymphoma: outcome after treatment with combination chemotherapy." Gynecologic Oncology 64, no. 3 (1997): 446-50.

Fontelonga, A., et al. "A novel high-dose chemotherapy protocol with autologous hematopoietic rescue in patients with metastatic breast cancer or recurrent non-Hodgkin's lymphoma." Bone Marrow Transplantation 19, no. 10 (1997): 983-88.

Freilone, R., et al. "Combined modality treatment with a weekly brief chemotherapy (ACOP-B) followed by locoregional radiotherapy in localized-stage intermediate- to high-grade non-Hodgkin's lymphoma." Annals of Oncology 7, no. 9 (1996): 919-24.

Garay, G., et al. "Combination salvage chemotherapy with MIZE (ifosfamide-mesna, idarubicin and etoposide) for relapsing or refractory lymphoma." Leukemia and Lymphoma 26, nos. 5-6 (1997): 595-02.

Haim, N., et al. "Dexamethasone, etoposide, ifosfamide, and cisplatin as second-line therapy in patients with aggressive non-Hodgkin's lymphoma." Cancer 80, no. 10 (1997): 1989-96.

Karakas, T., et al. "Peripheral T-cell lymphomas respond well to vincristine, adriamycin, cyclophosphamide, prednisone and etoposide (VACPE) and have a similar outcome as high-grade B-cell lymphomas." Leukemia and Lymphoma 24, nos. 1-2 (1996): 121-29.

Lane, P. A. "The spleen in children." Current Opinion in Pediatrics 7, no. 1 (1995): 36-41.

Lauria, F., et al. "Immunologic and clinical modifications following low-dose subcutaneous administration of rIL-2 in non-Hodgkin's lymphoma patients after autologous bone marrow transplantation." Bone Marrow Transplantation 18, no. 1 (1996): 79-85.

Lerner, Michael. Choices in Healing : Integrating the Best of Conventional and Complementary Approaches to Cancer. Cambridge: The MIT Press, 1996.

MacInnes, J., Waghorn, D., and Haworth, E. "Management of asplenic patients in South Buckinghamshire: an audit of local practice." Communicable Disease Report CDR Review 10, no. 5 (1995): 173-77.

Mac Manus, M. P., and Hoppe, R. T. "Is radiotherapy curative for stage I and II low-grade follicular lymphoma? Results of a long-term follow-up study of patients treated at Stanford University." Journal of Clinical Oncology 14, no. 4 (1996): 1282-90.

Mahendra, P., et al. "High-dose therapy and autologous stem cell rescue for poor risk and refractory lymphoma: A single centre experience of 123 patients." Bone Marrow Transplantation 17, no. 6 (1996): 973-78.

Majolino, I., et al. "Peripheral-blood stem-cell transplantation versus autologous bone marrow transplantation in Hodgkin's and non-Hodgkin's lymphomas: A new matched-pair analysis of the European Group for Blood and Marrow Transplantation Registry Data." Journal of Clinical Oncology 15, no. 2 (1997): 509-17.

Maloney, D. G., et al. "IDEC-C2B8 (Rituximab) anti-CD20 monoclonal antibody therapy in patients with relapsed low-grade non-Hodgkin's lymphoma." Blood 90, no. 6 (1997): 2188-95.

Martinsson, P., et al. "Cytotoxic activity of cyclosporin A and [3-keto-Bmt1]-[Val2]-cyclosporin (SDZ PSC 833) on tumour cells from patients with haematological malignancies." European Journal of Clinical Pharmacology 52, no. 3 (1997): 199-03.

Meehan, K. R., et al. "A pilot study evaluating interleukin-2-activated hematopoietic stem cell transplantation for hematologic malignancies." Journal of Hematotherapy 6, no. 5 (1997): 457-64.

Munck, J. N., et al. "Alternating chemotherapy and radiotherapy for limited-stage intermediate and high-grade non-Hodgkin's lymphomas: Long-term results for 96 patients with tumors > 5 cm." Annals of Oncology 7, no. 9 (1996): 925-31.

Nagler, A., et al. "Immunotherapy with recombinant human interleukin-2 and recombinant interferon-alpha in lymphoma patients postautologous marrow or stem cell transplantation." Blood 89, no. 11 (1997): 3951-59.

Niitsu, N., and Umeda, M. "Salvage chemotherapy for relapsed or refractory non-Hodgkin's lymphoma with a combination of ACES (high-dose Ara C, carboplatin,etoposide and steroids) therapy." European Journal of Haematology 57, no. 4 (1996): 320-24.

Niitsu, N., and Umeda, M. "Evaluation of long-term daily administration of oral low-dose etoposide in elderly patients with relapsing or refractory non-Hodgkin's lymphoma." Journal of Clinical Oncology 20, no. 3 (1997): 311-14.

Niitsu, N., and Umeda, M. "THP-COPBLM (pirarubicin, cyclophosphamide, vincristine, prednisone, bleomycin and procarbazine) regimen combined with granulocyte colony-stimulating factor (G-CSF) for non-Hodgkin's lymphoma in elderly patients: A prospective study." Leukemia 11, no. 11 (1997): 1817-20.

Magrath, editor. The Non-Hodgkin's Lymphomas, 2nd edition. London: Arnold and Oxford University Press, 1997.

The National Cancer Institute's PDQ State-of-the-Art Treatment Statements for Physicians on: Adult non-Hodgkin's lymphoma, Childhood non-Hodgkin's lymphoma, Childhood acute lymphocytic leukemia, Cutaneous T-cell lymphoma, AIDS-related lymphoma.

Ogura, M., et al. "Phase I/II trial of cure-oriented high-dose chemoradiotherapy with transplantation of CD34+ peripheral blood stem cells purified by the immunomagnetic bead method for refractory hematological malignancies." Cancer Chemotherapy and Pharmacology 40 (1997): S51-S57.

Petrasch, S., et al. "Antibody responses of splenectomized patients with non-Hodgkin's lymphoma to immunization with polyvalent pneumococcal vaccines." Clinical and Diagnostic Laboratory Immunology 4, no. 6 (1997): 635-38.

Pettengell, R., et al. "Survival benefit from high-dose therapy with autologous blood progenitor-cell transplantation in poor-prognosis non-Hodgkin's lymphoma." Journal of Clinical Oncology 14, no. 2 (1996): 586-92.

PharmInfoNet: http://pharminfo.com

Rodriguez-Monge, E., and Cabanillas, F. "Long-term follow-up of platinum-based lymphoma salvage regimens. The M.D. Anderson Cancer Center experience." Hematology and Oncology Clinics of North America 11, no. 5 (1997): 937-47.

RxList: http://www.rxlist.com

Savarese, D., Hsieh, C., and Stewart, F. "Clinical impact of chemotherapy dose escalation in patients with hematologic malignancies and solid tumors." Journal of Clinical Oncology 15, no. 8 (1997): 2981-95.

Schenkein, D. P., et al. "A phase II multicenter trial of high-dose sequential chemotherapy and peripheral blood stem cell transplantation as initial therapy for patients with high-risk non-Hodgkin's lymphoma." Biology of Blood and Marrow Transplantation 3, no. 4 (1997): 210-16.

Schouten, I. C., et al. "High-dose therapy followed by bone marrow transplantation for relapsed follicular non-Hodgkin's lymphoma." Annals of Hematology 73, no. 6 (1996): 273-77.

Sharma, H. L., et al. "Treatment of lymphoid cell malignancy with In-114m labelled autologous lymphocytes." Anticancer Research 13, no. 3B (1997): 1815-21.

Stamatoullas, A., et al "Ifosfamide, etoposide, cytarabine, and methotrexate as salvage chemotherapy in relapsed or refractory aggressive non-Hodgkin's lymphoma." Cancer 77, no. 11 (1996): 2302-07.

Stamatoullas, A., et al. "Peripheral blood stem cell transplantation for relapsed or refractory aggressive lymphoma in patients over 60 years of age." Bone Marrow Transplantation 19, no. 1 (1997): 31-35.

Stockerl-Goldstein, K. E., et al. "Influence of preparatory regimen and source of hematopoietic cells on outcome of autotransplantation for non-Hodgkin's lymphoma." Biology of Blood and Marrow Transplantation 2, no. 2 (1996): 76-85.

Stoppa, A. M., et al. "Intensive sequential chemotherapy with repeated blood stem-cell support for untreated poor-prognosis non-Hodgkin's lymphoma." Journal of Clinical Oncology 15, no. 5 (1997): 1722-29.

Stuschke, M., et al. "Extended field and total central lymphatic radiotherapy in the treatment of early stage lymph node centroblastic-centrocytic lymphomas: results of a prospective multicenter study. Study Group NHL-fruhe Stadien." Cancer 80, no. 12 (1997): 2273-84.

Sweetenham, J. W., et al. "Adult Burkitt's and Burkitt-like non-Hodgkin's lymphoma--outcome for patients treated with high-dose therapy and autologous stem-cell transplantation in first remission or at relapse: results from the European Group for Blood and Marrow Transplantation." Journal of Clinical Oncology 14, no. 9 (1996): 2465-72.

Tirelli, U., et al. "Long-term survival of patients with HIV-related systemic non-Hodgkin's lymphomas." Hematological Oncology 14, no. 1 (1996):7-15.

van Besien, K., et al. "Allogeneic transplantation for recurrent or refractory non-Hodgkin's lymphoma with poor prognostic features after conditioning with thiotepa, busulfan, and cyclophosphamide: Experience in 44 consecutive patients." Biology of Blood and Marrow Transplantation 3, no. 3 (1997): 150-56.

Vandenberghe, E., et al. "Role of a second transplant in the management of poor-prognosis lymphomas: A report from the European Blood and Bone Marrow Registry." Journal of Clinical Oncology 15, no. 4 (1997): 1595-600.

Verdonck, L. F., et al. "Allogeneic versus autologous bone marrow transplantation for refractory and recurrent low-grade non-Hodgkin's lymphoma." Blood 90, no. 10 (1997): 4201-05.

Vey, N., et al. "A pilot study of autologous bone marrow transplantation followed by recombinant interleukin-2 in malignant lymphomas." Leukemia and Lymphoma 21, nos. 1-2 (1996): 107-14.

Vose, J. M. "Dose-intensive ifosfamide for the treatment of non-Hodgkin's lymphoma." Seminars in Oncology 23, no. 3 (1996): 33-37.

Weaver, C. H., et al. "High-dose chemotherapy and peripheral blood stem cell infusion in patients with non-Hodgkin's lymphoma: Results of outpatient treatment in community cancer centers." Bone Marrow Transplantation 20, no. 9 (1997): 753-60.

Williams, C. D., et al. "Purging of bone marrow in autologous bone marrow transplantation for non-Hodgkin's lymphoma: A case-matched comparison with unpurged cases by the European Blood and Marrow Transplant Lymphoma Registry." Journal of Clinical Oncology 14, no. 9 (1996): 2454-64.

Wolf, M., et al. "Long-term survival advantage of MACOP-B over CHOP in intermediate-grade non-Hodgkin's lymphoma. The Australian and New Zealand Lymphoma Group." Annals of Oncology 8, no. 1 (1997): 71-75.

Zinzani, P. L. "Idarubicin in low-grade non-Hodgkin's lymphomas." Haematologica 82, no. 5 (1997): 23-24.

Chapter 7: What to Expect During Chemotherapy

Drum, D. Making the Chemotherapy Decision. Los Angeles: Lowell House, 1997.

Dollinger, M., Rosenbaum, E., and Cable, G. editors. Everyone's Guide to Cancer Therapy. Andrews & McMeel, 1998.

Harpham, Wendy Schlessel. Diagnosis: Cancer. New York: W. W. Norton, 1998.

Johnson, J. and Klein, L. I Can Cope : Staying Healthy With Cancer. Minneapolis: Chronimed, 1994.

Keene, Nancy. Childhood Leukemia: A Guide for Families, Friends, and Caregivers. Sebastopol: O'Reilly & Associates, 1997.

McKay, J., Hirano, N., and Lampenfeld, M. The Chemotherapy & Radiation Therapy Survival Guide. New Harbinger Publications, 1998.

Magrath, editor. The Non-Hodgkin's Lymphomas, 2nd edition. London: Arnold and Oxford University Press, 1997.

Murphy, G., Morris, L., and Lange, D., editors. Informed Decisions - The Complete Book of Cancer Diagnosis, Treatment and Recovery. The American Cancer Society. New York: Viking Press, 1997.

Chapter 8: What to Expect During Radiotherapy

Brenner, David, and Hall, Eric. Making the Radiation Therapy Decision. Los Angeles: Lowell House, 1997.

Cukier, Daniel, and McCullough, Virginia. Coping with Radiation Therapy: A Ray of Hope. Los Angeles: Lowell House, 1997.

Dollinger, M., Rosenbaum, E., and Cable, G. editors. Everyone's Guide to Cancer Therapy. Andrews & McMeel, 1998.

Harpham, Wendy Schlessel. Diagnosis: Cancer. New York: W. W. Norton, 1998.

Murphy, G., Morris, L., and Lange, D., editors. Informed Decisions - The Complete Book of Cancer Diagnosis, Treatment and Recovery. The American Cancer Society. New York: Viking Press, 1997.

Johnson, J., and Klein, L. I Can Cope : Staying Healthy With Cancer. Minneapolis: Chronimed, 1994.

Keene, Nancy. Childhood Leukemia: A Guide for Families, Friends, and Caregivers. Sebastopol: O'Reilly & Associates, 1997.

Magrath, editor. The Non-Hodgkin's Lymphomas, 2nd edition. London: Arnold and Oxford University Press, 1997.

McKay, J., Hirano, N., and Lampenfeld, M. The Chemotherapy & Radiation Therapy Survival Guide. New Harbinger Publications, 1998.

Radiation Therapy and You, a fifty-page booklet, is available from the U.S. National Cancer Institute by calling 1-800-4-CANCER.

Chapter 9: Side Effects of Treatment

Brenner, David, and Hall, Eric. Making the Radiation Therapy Decision. Los Angeles: Lowell House, 1997.

Cukier, Daniel, and McCullough, Virginia. Coping with Radiation Therapy: A Ray of Hope. Los Angeles: Lowell House, 1997.

Drum, D. Making the Chemotherapy Decision. Los Angeles: Lowell House, 1997.

Dollinger, M., Rosenbaum, E., and Cable, G. editors. Everyone's Guide to Cancer Therapy. Andrews & McMeel, 1998.

Harpham, Wendy Schlessel. Diagnosis: Cancer. New York: W. W. Norton, 1998.

Johnson, J., and Klein, L. I Can Cope : Staying Healthy With Cancer. Minneappolis: Chronimed, 1994.

Keene, Nancy. Childhood Leukemia: A Guide for Families, Friends, and Caregivers. Sebastopol: O'Reilly & Associates, 1997.

Magrath, editor. The Non-Hodgkin's Lymphomas, 2nd edition. London: Arnold and Oxford University Press, 1997.

McKay, J., Hirano, N., and Lampenfeld, M. The Chemotherapy & Radiation Therapy Survival Guide. New Harbinger Publications, 1998.

Murphy, G., Morris, L., and Lange, D., editors. Informed Decisions - The Complete Book of Cancer Diagnosis, Treatment and Recovery. The American Cancer Society. New York: Viking Press, 1997.

The National Cancer Institute's PDQ State-of-the-Art Treatment Statements for Physicians on: Constipation, impaction, and bowel obstruction, Delirium, Fatigue, Fever, chills, and sweats, Hypercalcemia, Lymphedema, Nausea and vomiting, Nutrition, Oral complications secondary to cancer therapy, Pain, Pruritus (itching), Radiation enteritis, Sleep disorders.

Zukerman, Eugenia, and Ingelfinger, Julie. Coping With Prednisone - and other cortisone-related medicines. New York: St. Martin's Press, 1997.

Chapter 10: If You're Hospitalized

Hoffman, Barbara, editor. A Cancer Survivor's Almanac. The National Coalition for Cancer Survivorship. Minneapolis: Chronimed, 1996.

American Medical Association Directory of Physicians in the U.S. . Published by the American Medical Association, 1996.

Crane, Judy B. How to Survive Your Hospital Stay. Westlake Village: The Center Press, 1997.

Keene, Nancy. Childhood Leukemia: A Guide for Families, Friends, and Caregivers. Sebastopol: O'Reilly & Associates, 1997.

Magrath, editor. The Non-Hodgkin's Lymphomas, 2nd edition. London: Arnold and Oxford University Press, 1997.

Olson, Kaye, R. N. Surgery and Recovery : How to Reduce Anxiety and Promote Healthy Healing. Traverse City: Rhodes and Easton, 1998.

Youngson, Robert with the Diagram Group The Surgery Book New York: St. Martin's Press, 1993.

Chapter 11: Stress and the Immune System

Andersen, B., Kiecolt-Glaser, J., and Glaser, R. "A biobehavioral model of cancer stress and disease course." American Psychologist 49, no. 5 (1994): 389-04.

Berk, L. S., et al "Neuroendocrine and stress hormone changes during mirthful laughter." American Journal of Medical Science 298, no. 6 (1989): 390-96.

Carlson, Richard. Don't Sweat the Small Stuff ... And It's All Small Stuff. New York: Hyperion, 1997.

Cooper, Cary, and Watson, Maggie. Cancer and Stress: Psychological, Biological and Coping Studies. New York: John Wiley & Sons, 1996.

Cousins, Norman. Anatomy of an Illness as Perceived by the Patient. New York: W. W. Norton, 1979.

Dimeo, F. C., et al. "Aerobic exercise in the rehabilitation of cancer patients after high dose chemotherapy and autologous peripheral stem cell transplantation" Cancer 79, no. 9 (1997): 1717-22.

Frankenfield, P. K. "The power of humor and play as nursing interventions for a child with cancer: A case report." Journal of Pediatric Oncology Nursing 13, no. 1 (1996): 15-20.

Friedman, A., Klein, T., and Friedman, H. Psychoneuroimmunology, Stress, and Infection. New York: CRC Press, 1996.

Friedman, E. M., and Irwin, M. R. "Modulation of immune cell function by the autonomic nervous system." Pharmacology and Therapeutics 74, no 1 (1997): 27-38.

Glaser, Ronald, and Kiecolt-Glaser, Janice. Handbook of Human Stress and Immunity. New York: Academic Press, 1994.

Goleman, Daniel. Emotional Intelligence. New York: Bantam, 1995.

Marwick, C. "Should physicians prescribe prayer for health? Spiritual aspects of well-being considered." Journal of the American Medical Association 273, no. 21 (1996): 1561-62.

Jonas, B. S., Franks, P., and Ingram, D. D. "Are symptoms of anxiety and depression risk factors for hypertension? Longitudinal evidence from the National Health and Nutrition Examination Survey I - Epidemiologic Follow-up Study." Archives of Family Medicine 6, no. 1 (1997): 43-49.

Jonsdottir, I. H., et al. "Duration and mechanisms of the increased natural cytotoxicity seen after chronic voluntary exercise in rats." Acta Physiologica Scandinavica 160, no. 4 (1997): 333-39.

Hoffman-Goetz, L., Arumugam, Y., and Sweeny, L. "Lymphokine activated killer cell activity following voluntary physical activity in mice." Journal of Sports Medicine and Physical Fitness 34, no. 1 (1994): 83-90.

Houldin, A., McCorkle, R., and Lowery, B. "Relaxation training and psychoimmunological status of bereaved spouses - A pilot study." Cancer Nursing 16, no 1. (1993): 47-52.

Lerner, Michael. Choices in Healing: Integrating the Best of Conventional and Complementary Approaches to Cancer. Cambridge: The MIT Press, 1996.

Li, J., and Xu, F. "Influences of light-dark shifting on the immune system, tumor growth and life span of rats, mice and fruit flies as well as on the counteraction of melatonin." Biological Signals 6, no. 2 (1997): 77-89.

Maes, M., et al. "Increased serum IL-6 and IL-1 receptor antagonist concentrations in major depression and treatment resistant depression." Cytokine 9, no. 11 (1997): 853-58.

Maes, M., et al. "Lower serum zinc in major depression is a sensitive marker of treatment resistance and of the immune/inflammatory response in that illness." Biological Psychiatry 42, no. 5 (1997): 349-58.

Magill-Levreault, L. "Music therapy in pain and symptom management." Palliative Care 9, no. 4 (1993): 42-48.

Massion, A. O., et al. "Meditation, melatonin and breast/prostate cancer: Hypothesis and preliminary data." Med Hypotheses 44, no. 1 (1995): 39-46.

McDaniel, J. S., et al. "Depression in patients with cancer. Diagnosis, biology, and treatment." Archives of General Psychiatry 52, no. 2 (1995): 89-99.

McElroy, Susan. Animals as Teachers and Healers. New York: Ballantine, 1997.

Medina, J. H., et al. "Overview--flavonoids: a new family of benzodiazepine receptor ligands." Neurochemistry Research 22, no. 4 (1997): 419-25.

Morris, Desmond. The Human Animal : A Personal View of the Human Species. New York: Crown Publishers, 1994.

Neuhaus, W., et al. "A prospective study concerning psychological characteristics of patients with breast cancer." Archives of Gynecology and Obstetrics 255, no 4 (1994): 201-09.

Nieman, D. C., et al. "Effects of long-endurance running on immune system parameters and lymphocyte function in experienced marathoners." International Journal of Sports Medicine 10, no. 5 (1989): 317-23.

Magrath, editor. The Non-Hodgkin's Lymphomas, 2nd edition. London: Arnold and Oxford University Press, 1997.

The National Cancer Institute's PDQ State-of-the-Art Treatment Statements for Physicians on: Anxiety Disorder, Depression, Post-traumatic Stress Disorder.

Persengiev, S., and Kyurkchiev, S. "Selective effect of melatonin on the proliferation of lymphoid cells." International Journal of Biochemistry 25, no. 3 (1993): 441-44.

Sabo, C. E., and Michael, S. R. "The influence of personal message with music on anxiety and side effects associated with chemotherapy." Cancer Nursing 19, no. 4 (1996): 283-89.

Schag, C. A., and Heinrich, R. L. "Anxiety in medical situations: adult cancer patients." Journal of Clinical Psychology 45, no. 1 (1989): 20-27.

Schwarz, R., and Geyer, S. "Social and psychological differences between cancer and noncancer patients: Cause or consequence of the disease?' Psychotherapy and Psychosomatics 41, no. 4 (1984): 195-99.

Shephard, R. J. "Exercise and relaxation in health promotion." Sports Medicine 23, no. 4 (1997): 211-17.

Shephard, R. J., and Shek, P. N. "Cancer, immune function, and physical activity." Canadian Journal of Applied Physiology 20, no. 1 (1995): 1-25.

Siebert, Al. The Survivor Personality. Portland: Practical Psychology Press, 1994.

Spiegel, David. "Cancer and depression." British Journal of Psychiatry Supplement 30 (1996): 109-16.

Spiegel, David. Living Beyond Limits: New Hope and Health for Facing Life-Threatening Illness. New York: Fawcett Columbine, 1994.

Watkins, G. R. "Music therapy: proposed physiological mechanisms and clinical implications." Clinical Nursing Specialties 11, no. 2 (1997): 43-50.

Yoshino, S., Fujimori, J., and Kohda, M. "Effects of mirthful laughter on neuroendocrine and immune systems in patients with rheumatoid arthritis." Journal of Rheumatology 23, no. 4 (1996): 793-94.

Chapter 12: Interacting with Medical Personnel

Cassell, Eric, M.D. The Healer's Art: A New Approach to the Doctor-Patient Relationship. Philadelphia: J.B. Lippincott Co., 1979.

Handler, Evan. Time on Fire: My Comedy of Terrors. New York: Little, Brown & Co., 1996.

Heymann, Jody, M.D. Equal Partners: A Physician's Call for a New Spirit of Medicine. New York: Little, Brown & Co., 1995.

Katz, Jay. The Silent World of Doctor and Patient. New York: The Free Press, 1984.

Keene, Nancy. Working With Your Doctor: Getting the Healthcare You Deserve. Sebastopol: O'Reilly & Associates, 1998.

Inlander, Charles B., editor. People's Medical Society Health Desk Reference: Information Your Doctor Can't or Won't Tell You. New York: Hyperion, 1996.

Rosenbaum, Edward, M.D. A Taste of My Own Medicine. New York: Random House, 1998.

Rosenfeld, Isadore, M.D. Second Opinion: Your Medical Alternatives. New York: Simon & Schuster, 1981.

Chapter 13: Getting Support

Hoffman, Barbara, editor. A Cancer Survivor's Almanac. The National Coalition for Cancer Survivorship. Minneapolis: Chronimed, 1996.

Boberg, Eric, Gustafson, David, and Hawkins, Robert, et al. "CHESS: The Comprehensive Health Enhancement Support System." in Information Networks for Community Health. Edited by Patricia Brennan. New York: Springer-Verlag, 1997.

Dollinger, M., Rosenbaum, E., and Cable, G., editors. Everyone's Guide to Cancer Therapy. Toronto: Somerville House Books Limited, 1991.

Foster, George, and Anderson, Barbara. Medical Anthropology. New York: John Wiley & Sons, 1978.

Harpham, Wendy Schlessel. When a Parent Has Cancer: A Guide to Caring for Your Children. HarperCollins, 1997.

Harpham, Wendy Schlessel. After Cancer: A Guide to Your New Life. New York: Norton, 1994.

Murphy, G., Morris, L., and Lange, D., editors. Informed Decisions - The Complete Book of Cancer Diagnosis, Treatment and Recovery. The American Cancer Society. New York: Viking Press, 1997.

Schultz, Ellen E. "If You Use Firm's Counselors, Remember Your Secrets Could Be Used Against You." The Wall Street Journal. May 26, 1994.

Spiegel, David. Living Beyond Limits. New York: Fawcett Columbine, 1993.

Chapter 14: Insurance, Finances, Employment, Record-keeping

1997 Social Security Handbook, 13th Ed.: http://www.ssa.gov/OP_Home/ handbook/ssa-hbk.htm

Abromovitz, Les. Family Insurance Handbook: The Complete Guide for the 1990s. Blue Ridge Summit: TAB Books, 1990.

Cash, Connaght. The Medicare Answer Book: What You and Your Family Need to Know Now! . Provincetown: Race Point Press, 1997.

Detlefs, Dale, Myers, Robert, and Treanor, J. R. 1997 Mercer Guide to Social Security & Medicare. William M. Mercer, Inc.

Enteen, Robert. Health Insurance: How to Get It, Keep It, or Improve What You've Got. New York: Paragon House, 1992.

Hakin, Cliff. When You Lose Your Job. San Francisco: Berrett-Loehler Publishers, 1993.

Inlander, Charles, and Donio, Michael. Medicare Made Easy. Allentown: People's Medical Society, 1998.

Nickel, Gudrun Maria, Esq. Debtors' Rights. Clearwater: Sphinx Publishing, 1998.

Porter, Steven L. Save Your Home!: How to Protect Your Home and Property from Foreclosure. Colorado Springs: Java Publishing Co., 1990.

Shernoff, William M., Esq. How to Make Insurance Companies Pay Your Claims And What to Do if They Don't. Mamaroneck: Hastings House, 1990.

Stern, Ken. Comprehensive Guide to Social Security and Medicare. Hawthorne: The Career Press, 1995.

Ventura, John. Fresh Start!: Survivng Money Troubles. Dearborn Financial Publishing, Inc., 1992.

Westhem, Andrew, and Korn, Donald J. Protecting What's Yours: How to Safeguard Your Assets and Maintain Your Personal Wealth. New York: Carol Publishing Group, 1995.

Chapter 15: After Treatment Ends

Harpham, Wendy. After Cancer: A Guide to Your New Life. New York: Norton, 1994.

Keene, Nancy. Childhood Leukemia: A Guide for Families, Friends, and Caregivers. Sebastopol: O'Reilly & Associates, 1997.

Lilenbaum, R. C., Lilenbaum, A. M., and Hryniuk, W. M. "Interleukin 2-induced focal fatty infiltrate of the liver that mimics metastases." Journal of the National Cancer Institute 87, no. 8 (1995): 609-10.

Magrath, editor. The Non-Hodgkin's Lymphomas, 2nd edition. London: Arnold and Oxford University Press, 1997.

The National Cancer Institute's PDQ State-of-the-Art Treatment Statements for Physicians on: Anxiety disorder, Depression, Fatigue, Lymphedema, Nutrition, Oral complications secondary to cancer therapy, Pain, Post-traumatic stress disorder, Pruritus, Radiation enteritis, Skin integrity changes secondary to cutaneous metastases, Sleep disorders.

Chapter 16: Late Effects, Late Complications

Bowers, D. G. Jr., and Lynch, J. B. "Adriamycin extravasation." Plastic and Reconstructive Surgery 61, no. 1 (1978): 86-92.

Bush, N. E., et al. "Quality of life of 125 adults surviving 6-18 years after bone marrow transplantation." Social Science and Medicine 40, no 4 (1995): 479-90.

Devlen, J., et al. "Psychological problems associated with diagnosis and treatment of lymphomas. I: Retrospective study." British Medical Journal 295, no. 6604 (1987): 953-54.

Devlen, J., et al. "Psychological problems associated with diagnosis and treatment of lymphomas. II: Prospective study." British Medical Journal 17, no. 295 (1987):955-57.

du Bois, A., et al. "Paclitaxel-induced "recall" soft tissue ulcerations occurring at the site of previous subcutaneous administration of paclitaxel in low doses." Gynecologic Oncology 60, no. 1 (1996): 94-96.

Dutton, C. M., et al. "Bone tired: The experience of fatigue and its impact on quality of life." Oncology Nursing Forum 23, no. 10 (1996): 1539-47.

Erdogan, G., et al. "Non-Hodgkin's lymphoma presenting as thyroid and adrenal gland involvement." Endocrine Journal 44, no. 1 (1997): 199-03.

Fobair, P., et al. "Psychosocial problems among survivors of Hodgkin's disease." Journal of Clinical Oncology 4, no. 5 (1986): 805-14.

Harpham, Wendy. After Cancer: A Guide to Your New Life. New York: W. W. Norton, 1994.

Kasperlik-Zaluska, A., Czarnocka, B., and Czech, W. "High prevalence of thyroid autoimmunity in idiopathic Addison's disease." Autoimmunity 18, no. 3 (1994): 213-16.

Keilholz, U., et al. "Long-term endocrine toxicity of myeloablative treatment followed by autologous bone marrow/blood derived stem cell transplantation in patients with malignant lymphohematopoietic disorders." Cancer 64, no. 3 (1989): 641-45.

Kelly, W. "Exophthalmos in Cushing's syndrome." Clinical Endocrinology 45, no. 2 (1996): 167-70.

Ljungman, P., et al. "Busulfan concentration in relation to permanent alopecia in recipients of bone marrow transplants." Bone Marrow Transplantation 15, no. 6 (1995): 869-71.

Mallon, E., et al. "Evidence for altered cell-mediated immunity in postmastectomy lymphoedema." British Journal of Dermatology 137, no. 6 (1997): 928-33.

Munck, J. N., et al. "Alternating chemotherapy and radiotherapy or limited-stage intermediate and high-grade non-Hodgkin's lymphomas: Long-term results for 96 patients with tumors > 5 cm." Annals of Oncology 7, no. 9 (1996): 925-31.

Magrath, editor. The Non-Hodgkin's Lymphomas, 2nd edition. London: Arnold and Oxford University Press, 1997.

Oberfield, S. E., et al. "Endocrine late effects of childhood cancers." Journal of Pediatrics 131, no. 1 (1997): 37-41.

Olver, I. N., et al. "A prospective study of topical dimethyl sulfoxide for treating anthracycline extravasation" Journal of Clinical Oncology 6, no. 11 (1988): 1732-35.

The National Cancer Institute's PDQ State-of-the-Art Treatment Statements for Physicians on: Anxiety disorder, Constipation, impaction, and bowel obstruction, Depression, Fatigue, Lymphedema, Nausea and vomiting, Nutrition, Oral complications secondary to cancer therapy, Pain, Post-traumatic stress disorder, Pruritus, Radiation enteritis, Skin integrity changes secondary to cutaneous metastases, Sleep disorders.

Schwartz, M. W., Strack, A. M., and Dallman, M. F. "Evidence that elevated plasma corticosterone levels are the cause of reduced hypothalamic corticotrophin-releasing hormone gene expression in diabetes." Regulatory Peptides 72, nos. 2-3 (1997): 105-12.

Shanks, J. H., et al. "Angiotropic lymphoma with endocrine involvement." Histopathology 31, no. 2 (1997): 161-66.

Soest, R., and Muller-Lissner, S. "Clinical manifestation of adrenal cortex insufficiency during thyroid hormone substitution." Deutsche Medizinische Wochenschrift 121, no. 13, (1996): 406-08.

Tanaka, H., et al. "Second primary cancers following non-Hodgkin's lymphoma in Japan: increased risk of hepatocellular carcinoma." Japanese Journal of Cancer Research 88, no. 6 (1997): 537-42.

Travis, L. B., et al. "Bladder and kidney cancer following cyclophosphamide therapy for non-Hodgkin's lymphoma." Journal of the National Cancer Instutute 87, no. 7 (1995): 524-30.

van Leeuwen, F. E. "Risk of acute myelogenous leukaemia and myelodysplasia following cancer treatment." Baillieres Clinical Haematology 9, no. 1 (1996): 57-85.

Vowels, M., et al. "Factors affecting hair regrowth after bone marrow transplantation." Bone Marrow Transplantation 12, no. 4 (1993): 347-50.

Whitmyer, C. C., Waskowski, J. C., and Iffland, H. A. "Radiotherapy and oral sequelae: Preventive and management protocols." Journal of Dental Hygiene 71, no. 1 (1997): 23-29.

Yellin, A., and Benfield, J. "Pneumothorax associated with lymphoma." American Review of Respiratory Disease 134, no. 3 (1986): 590-92.

Younes, A., et al. "Phase I study of fludarabine and paclitaxel for the treatment of low-grade non-Hodgkin's lymphoma." Leukemia and Lymphoma 26, nos. 1-2 (1997): 77-82.

Chapter 17: Sexuality and Fertility After Treatment

Adami, H. O., et al. "Pregnancy and risk of non-Hodgkin's lymphoma: a prospective study." International Journal of Cancer 70, no. 2 (1997): 155-58.

al-Jitawi, S. A., al-Ramahi, S. A., and Hakooz, B. A. "Diagnostic role of testicular fine needle aspiration biopsy in male infertility." Acta Cytologica 41, no. 6 (1997): 1705-08.

Asbjornsen, G., et al. "Testicular function after radiotherapy to inverted 'Y' field for malignant lymphoma." Scandinavian Journal of Haematology 17, no. 2 (1976): 96-100.

Aubier, F., et al. "Male gonadal function after chemotherapy for solid tumors in childhood." Journal of Clinical Oncology 7, no. 3 (1989): 304-09.

Aviles, A., et al. "Non-Hodgkin's lymphomas and pregnancy: Presentation of 16 cases." Gynecologic Oncology 37, no. 3 (1990): 335-37.

Blumenfeld, Z., and Haim, N. "Prevention of gonadal damage during cytotoxic therapy." Annals of Medicine 29, no. 3 (1997): 199-206.

Byrne, J., et al. "Effects of treatment on fertility in long-term survivors of childhood or adolescent cancer." New England Journal of Medicine 317, no. 21 (1987): 1315-21.

Byrne, J., et al. "Early menopause in long-term survivors of cancer during adolescence." American Journal of Obstetrics and Gynecology 1992 Mar;166(3): 788-93.

Chen, S. U., et al. "Pregnancy achieved by intracytoplasmic sperm injection using cryopreserved semen from a man with testicular cancer." Human Reproduction 11, no. 12 (1996): 2645-47.

Clark, S. T., et al. "Gonadal function following chemotherapy for Hodgkin's disease: A comparative study of MVPP and a seven-drug hybrid regimen." Journal of Clinical Oncology 13, no. 1 (1995): 134-39.

Critchley, H. O., et al. "Abdominal irradiation in childhood: The potential for pregnancy." British Journal of Obstetrics and Gynaecology 99, no. 5 (1992): 392-94.

Crowne, E. C., et al. "A novel variant of growth hormone (GH) insufficiency following low dose cranial irradiation." Clinical Endocrinology 36, no. 1 (1992): 59-68.

Damewood, M. D., et al. "Induction of ovulation and pregnancy following lateral oophoropexy for Hodgkin's disease." International Journal of Gynaecology and Obstetrics 33, no. 4 (1990): 369-71.

Davies, H. A., et al. "Growth, puberty and obesity after treatment for leukaemia." Acta Paediatrica. Supplement 411, (1995): 45-50.

Devlen, J., et al. "Psychological problems associated with diagnosis and treatment of lymphomas. II: Prospective study." British Medical Journal (Clinical Research Edition) 295, no. 6604 (1987): 955-57.

Didcock, E., et al. "Pubertal growth in young adult survivors of childhood leukemia." Clinical Oncology 13, no. 10 (1995): 2503-07.

Didi, M., et al. "High incidence of obesity in young adults after treatment of acute lymphoblastic leukemia in childhood." Journal of Pediatrics 127, no. 1 (1995): 63-67.

Dollinger, M., Rosenbaum, E., and Cable, G. editors. Everyone's Guide to Cancer Therapy. Toronto: Somerville House Books Limited, 1991.

Farr, S. A., et al. "Testicular circulatory isolation in man: Comparison of radionuclide angiography with Doppler evaluation." Journal of Surgical Oncology 54, no. 1 (1993): 57-59.

Gelb, A. B., et al. "Pregnancy-associated lymphomas: A clinicopathologic study." Cancer 78, no. 2 (1996): 304-10.

Giovannini, M., et al. "Can pregnancy aggravate the course of non-Hodgkin's lymphoma?" European Journal of Gynaecologic Oncology 10, no. 4 (1989): 287-89.

Goldwasser, F., et al. "Successful chemotherapy including epirubicin in a pregnant non-Hodgkin's lymphoma patient." Leukemia and Lymphoma 20, nos. 1-2 (1995): 173-76.

Hakim, L. S., Lobel, S. M., and Oates, R. D. "The achievement of pregnancies using assisted reproductive technologies for male factor infertility after retroperitoneal lymph node dissection for testicular carcinoma." Fertility and Sterility 64, no. 6 (1995): 1141-46.

Halyard, M. Y., et al. "Prolonged amenorrhea associated with total nodal irradiation for Hodgkin's disease." Journal of the National Medical Association 88, no. 6 (1996): 391-93.

Harpham, W After Cancer - A Guide to Your New Life. 1994 Norton.

Herrmann, T. "Radiation reactions in the gonads: importance in patient counseling." Strahlentherapie und Onkologie 173, no. 10 (1997): 493-01.

Kader, H. A., and Rostom, A. Y. "Follicle stimulating hormone levels as a predictor of recovery of spermatogenesis following cancer therapy." Clinical Oncology 3, no. 1 (1991): 37-40.

Kazem, R., et al. "Cryopreservation of human oocytes and fertilization by two techniques: In-vitro fertilization and intracytoplasmic sperm injection." Human Reproduction 10, no. 10 (1995): 2650-54.

Kenney, L. B., et al. "Birth defects in offspring of adult survivors of childhood acute lymphoblastic leukemia -- A Childrens Cancer Group/National Institutes of Health Report." Cancer 78, no. 1 (1996): 169-76.

Kim, S. J., and Han, H. D. "In vitro retrieval of epididymal sperm: A new approach to achievement of pregnancy for post-testicular azoospermia." Fertility and Sterility 63, no. 3 (1995): 656-59.

Levy, M. J., and Stillman, R. J. "Reproductive potential in survivors of childhood malignancy." Pediatrician 18, no. 1 (1991): 61-70.

Lih, C. H., et al. "Development of a microchamber which spontaneously selects high-quality sperm for use in in-vitro fertilization or micromanipulation." Journal of Assisted Reproduction and Genetics 13, no. 8 (1996): 657-62.

Lishner M, et al. "Non-Hodgkin's lymphoma and pregnancy." Leukemia and Lymphoma 14, nos. 5-6 (1994): 411-13.

Mackie, E., Radford, M., and Shalet, S. "Gonadal function following chemotherapy for childhood Hodgkin's disease." Medical and Pediatric Oncology 27, no. 2 (1996): 74-78.

Masala, A., et al. "Use of testosterone to prevent cyclophosphamide-induced azoospermia." Annals of Internal Medicine 126, no. 4 (1997): 292-95.

McKay, J., and Hirano, N. The Chemotherapy Survival Guide. New Harbinger, 1993.

Meguerian-Bedoyan, Z., et al. "Anaplastic large cell lymphoma of maternal origin involving the placenta: Case report and literature survey." American Journal of Surgery and Pathology 21, no. 10 (1997): 1236-41.

Meistrich, M., and Kangasniemi, M. "Hormone treatment after irradiation stimulates recovery of rat spermatogenesis from surviving spermatogonia." Andrology 18, no. 1 (1997): 80-87.

Mills, J. L., et al. "Menarche in a cohort of 188 long-term survivors of acute lymphoblastic leukemia." Journal of Pediatrics 131, no. 4 (1997): 598-02.

Mulvihill, J. J., et al. "Cancer in offspring of long-term survivors of childhood and adolescent cancer." Lancet 2, no. 8563 (1987): 813-17.

Nantel, S., Parboosingh, J., and Poon, M. "Treatment of an aggressive non-Hodgkin's lymphoma during pregnancy with MACOP-B chemotherapy." Medical and Pediatric Oncology 18, no. 2 (1990): 143-45.

Nicholson, H., and Byrne, J. "Fertility and pregnancy after treatment for cancer during childhood or adolescence." Cancer 71, no. 10 (1993): 3392-99.

Magrath, editor. The Non-Hodgkin's Lymphomas, 2nd edition. London: Arnold and Oxford University Press, 1997.

The National Cancer Institute's PDQ State-of-the-Art Treatment Statements for Physicians on: Breast Cancer and Pregnancy, Non-Hodgkin's lymphoma during pregnancy.

Ogilvy-Stuart, A. L., and Shalet, S. M. "Effect of radiation on the human reproductive system." Environmental Health Perspectives 101, no. 2 (1993): 109-16.

Ogilvy-Stuart, A. L., Clayton, P. E., and Shalet, S. M. "Cranial irradiation and early puberty." Journal of Clinical Endocrinology and Metabolism 78, no. 6 (1994): 1282-86.

Ohl, D. A., and Sonksen, J. "What are the chances of infertility and should sperm be banked?" Seminars in Urologic Oncology 14, no. 1 (1996): 36-44.

Philip, T., Bergeron, C., and Frappaz, D. "Management of paediatric lymphoma." Baillieres Clinical Haematology 9, no. 4 (1996): 769-97.

Radford, J. A., et al. "Male fertility after VAPEC-B chemotherapy for Hodgkin's disease and non-Hodgkin's lymphoma." British Journal of Cancer 69, no. 2 (1994): 379-81.

Schover, L. Sexuality and Fertility After Cancer. New York: John Wiley & Sons, 1997.

Spitzer, M., et al. "Non-Hodgkin's lymphoma during pregnancy." Gynecologic Oncology 43, no. 3 (1991): 309-12.

Tavani, A., et al. "A case-control study of reproductive factors and risk of lymphomas and myelomas." Leukemia Research 21, no. 9 (1997): 885-88.

Toki, H., et al. "Successful chemotherapy on a pregnant non-Hodgkin's lymphoma patient." Acta Medica Okayama 44, no. 6 (1990): 321-23.

Toth, T. L., et al. "Cryopreservation of human prophase I oocytes collected from unstimulated follicles." Fertiity and Sterility 61, no. 6 (1994): 1077-82.

Wallace, W. H., et al. "Ovarian failure following abdominal irradiation in childhood: The radiosensitivity of the human oocyte." British Journal of Radiology 62, 743 (1989): 995-98.

Wallace, W. H., et al. "Ovarian failure following abdominal irradiation in childhood: natural history and prognosis." Clinical Oncology 1, no. 2 (1989): 75- 79.

Wallace, W. H., et al. "Male fertility in long-term survivors of childhood acute lymphoblastic leukaemia." International Journal of Andrology 14, no. 5 (1991): 312-19.

Wallace, W. H., et al. "Ovarian function following the treatment of childhood acute lymphoblastic leukaemia." Medical and Pediatric Oncology 21, no. 5 (1993): 333-39.

Wallace, W. H., and Kelnar, C. J. "Late effects of antineoplastic therapy in childhood on growth and endocrine function." Drug Safety 15, no. 5 (1996): 325-32.

Ward, J. A., et al. "Protection of spermatogenesis in rats from the cytotoxic procarbazine by the depot formulation of Zoladex, a gonadotropin-releasing hormone agonist." Cancer Research 50, no. 3 (1990): 568-74.

Williams, R. S., and Mendenhall, N. "Laparoscopic oophoropexy for preservation of ovarian function before pelvic node irradiation." Obstetrics and Gynecology 80, no. 3 (1992): 541-43.

Chapter 18: Relapse

Hoffman, Barbara, editor. A Cancer Survivor's Almanac. The National Coalition for Cancer Survivorship. Minneapolis: Chronimed, 1996.

The Alpha Book on Cancer and Living. The Alpha Institute. Alameda, CA, 1993.

Cousins, Norman. Anatomy of an Illness as Perceived by the Patient. New York: W. W. Norton, 1979.

Dollinger, M., Rosenbaum, E., and Cable, G. editors. Everyone's Guide to Cancer Therapy. Andrews & McMeel, 1994.

Murphy G., Morris L., and Lange D, editors. Informed Decisions - The Complete Book of Cancer Diagnosis, Treatment and Recovery. The American Cancer Society. New York: Viking Press, 1997.

Johnson, J. & Klein, L. I Can Cope: Staying Healthy With Cancer. Minneapolis: Chronimed, 1994.

Keene, Nancy. Childhood Leukemia: A Guide for Families, Friends, and Caregivers. Sebastopol: O'Reilly & Associates, 1997.

Kushner, Harold. When Bad Things Happen to Good People. G. K. Hall, 1982.

Lerner, Michael. Choices in Healing: Integrating the Best of Conventional and Complementary Approaches to Cancer. Cambridge: The MIT Press, 1996.

Lilenbaum, R. C., Lilenbaum, A. M., and Hryniuk, W. M. "Interleukin 2-induced focal fatty infiltrate of the liver that mimics metastases" Journal of the National Cancer Institute 87, no. 8 (1995): 609-10.

McAllister, Horowitz, and Gilden. Cancer. BasicBooks HarperCollins, 1993.

Magrath, editor. The Non-Hodgkin's Lymphomas, 2nd edition. London: Arnold and Oxford University Press, 1997.

Siebert, Al. The Survivor Personality. Practical Psychology Press, 1994.

Spiegel, David. Living Beyond Limits. New York: Fawcett Columbine, 1993.

Chapter 19: Clinical trials

The Alpha Book on Cancer and Living, Alameda: The Alpha Institute, 1993.

Dunn, Steve, CancerGuide http://www.cancerguide.org/sdunn_story.html

Dollinger, M., Rosenbaum, E., and Cable, G. editors. Everyone's Guide to Cancer Therapy. Toronto: Somerville House Books Limited, 1991.

Food and Drug Administration (FDA) website: http:///www.fda.gov

Harpham, Wendy. After Cancer: A Guide to Your New Life. New York: W.W. Norton, 1994.

Harpham, Wendy. Diagnosis: Cancer. New York: W.W. Norton, 1998.

Murphy, G., Morris, L., and Lange, D., editors. Informed Decisions - The Complete Book of Cancer Diagnosis, Treatment and Recovery. The American Cancer Society. New York: Viking Press, 1997.

Jensen, M., and Karoly, P. "Motivation and expectancy factors in symptom perception: a laboratory study of the placebo effect." Psychosomatic Medicine 53, no. 2 (1991): 144-52.

Keene, Nancy. Working With Your Doctor: Getting the Healthcare You Deserve. Sebastopol: O'Reilly & Associates, 1998.

McCann, C. C., et al. "The role of personality factors and suggestion in placebo effect during mental stress test." British Journal of Clinical Pharmacology 33, no. 1 (1992): 107-10.

Montgomery, G., and Kirsch, I. "Classical conditioning and the placebo effect." Pain 72, nos. 1-2 (1997): 107-13.

Moscucci, M., et al. "Blinding, unblinding, and the placebo effect: an analysis of patients' guesses of treatment assignment in a double-blind clinical trial." Clinical Pharmacology Therapy 41, no. 3 (1987): 259-65.

National Cancer Institute website for searching among clinical trial protocols: http://cancernet.nci.nih.gov/prot/protsrch.shtml

Magrath, editor. The Non-Hodgkin's Lymphomas, 2nd edition. London: Arnold and Oxford University Press, 1997.

Shirk, M. B., and Hale, K. N. "Obtaining drugs from foreign markets." American Journal of Hospital Pharmacies 49, no. 11 (1992): 2731-39.

Staats, P., and Hekmat, H. "Suggestion/placebo effects on pain: Negative as well as positive." Journal of Pain & Symptom Management 15, no. 4 (1998): 235-43.

Zakarian, Beverly. The Activist Cancer Patient. New York: John Wiley & Sons, 1996.

Chapter 20: Transplantation

Bone Marrow Transplantation and Peripheral Blood Stem Cell Transplantation National Cancer Institute http://cancernet.nci.nih.gov

Bortin, M. M. "A compendium of reported human bone marrow transplants." Transplantation 9, no. 6 (1970): 571-87.

Cavalli-Sforza, L., Menozzi, P., and Piazza, A. History and Geography of Human Genes. Princeton: University Press, 1996.

de Lima, M., et al. "Bone marrow transplantation after failure of autologous transplant for non-Hodgkin's lymphoma." Bone Marrow Transplantation 19, no. 2 (1997): 121-27.

Hess, A. D., et al. "Specificity of effector T lymphocytes in autologous graft-versus-host disease: Role of the major histocompatibility complex class II invariant chain peptide." Blood 89, no. 6 (1997): 2203-09.

Ilbery, P. L. "Thymic, lymphoid and marrow inocula in cytogenetic repopulation studies of irradiated mice." Australian Journal of Experimental Biological and Medical Sciences 43, no. 5 (1965): 579-92.

Murphy, G., Morris, L., and Lange, D., editors. Informed Decisions - The Complete Book of Cancer Diagnosis, Treatment and Recovery. The American Cancer Society. New York: Viking Press, 1997.

Keene, Nancy. Childhood Leukemia: A Guide for Families, Friends, and Caregivers. Sebastopol: O'Reilly & Associates, 1997.

Lower, F. E., et al. "Utility of DRB1 subtyping: A case report." Clinical Transplantation.

Miller, C. B., et al. "Impact of age on outcome of patients with cancer undergoing autologous bone marrow transplant." Journal of Clinical Oncology 14, no. 4 (1996): 1327-32.

Mori, M., et al. "HLA gene and haplotype frequencies in the North American population: The National Marrow Donor Program Donor Registry." Transplantation 64, no. 7 (1997): 1017-27.

Nakao, S., et al. "Induction of autocytotoxic T cells with cyclosporine and interferon-gamma for patients with non-Hodgkin's lymphoma after transplantation of peripheral blood stem cells." Journal of Allergy and Clinical Immunology 100, no. 6 (1997): S65-S69.

Magrath, editor. The Non-Hodgkin's Lymphomas, 2nd edition. London: Arnold and Oxford University Press, 1997.

Rambaldi, A., et al. "Innovative two-step negative selection of granulocyte colony-stimulating factor-mobilized circulating progenitor cells: Adequacy for autologous and allogeneic transplantation." Blood 91, no. 6 (1998): 2189-96.

Roots-Weiss, A., et al. "The efficiency of tumor cell purging using immunomagnetic CD34+ cell separation systems" Bone Marrow Transplantation 19, no. 12 (1997): 1239-46.

Schneiderman, M. H., et al. "Cell cycle-based purging of lymphoma cells from bone marrow harvests using radioiodinated 5-iodo-2'-deoxyuridine." Radiation Research 149, no. 2 (1998): 147-54.

Stewart, Susan L. Bone Marrow Transplants: A Book of Basics for Patients. BMT Newsletter, Highland Park, Illinois, 1992.

Tyan, M. L., and Cole, L. J. "Bone marrow as the major source of potential immunologically competent cells in the adult mouse." Nature 208, no. 16 (1965): 1223-24.

Vandenberghe, E., et al. "Role of a second transplant in the management of poor-prognosis lymphomas: A report from the European Blood and Bone Marrow Registry." Journal of Clinical Oncology 15, no. 4 (1997): 1595-1600.

Verdonck, L. F., et al. "Allogeneic versus autologous bone marrow transplantation for refractory and recurrent low-grade non-Hodgkin's lymphoma." Blood 90, no. 10 (1997): 4201-05.

Chapter 21: Traveling for Care

Mercy Medical Airlift http://www.mercymedical.org

Chapter 22: If All Treatments Fail

Basta, Lofty. A Graceful Exit: Life and Death on Your Own Terms. New York: Plenum Press, 1996.

Bernard, Jan and Schneider, Miriam. The True Work of Dying. New York: Avon Books, 1996.

Callanan, Maggie, and Kelley, Patricia. Final Gifts: Understanding the Special Awareness, Needs, and Communications of the Dying. New York: Bantam Books, 1997.

Furman, Joan, and Mc Nabb, David. The Dying Time: Practical Wisdom for the Dying. New York: Bell Tower, 1997.

Groopman, Jerome. The Measure of Our Days. New York: Viking Press, 1997.

Humphry, Derek. Final Exit: The Practicalities of Self-Deliverance and Assisted Suicide for the Dying. The Hemlock Society, 1997.

Kubler-Ross, Elisabeth. On Death and Dying. New York: MacMillan Publishing, 1969.

Kubler-Ross, Elisabeth. Death: The Final Stage of Growth. New York: Simon and Schuster, 1975.

Kubler-Ross, Elisabeth. To Live Until We Say Good-bye. New York: Fireside (Simon and Schuster), 1978.

Kubler-Ross, Elisabeth. Living With Death and Dying. New York: Touchstone (Simon and Schuster), 1981.

Lattanzi-Licht, Marcia, Mahoney, John; and Miller, Galen. The Hospice Choice: In Pursuit of a Peaceful Death. New York: Fireside (Simon and Schuster), 1998.

Mayer, Musa. Advanced Breast Cancer: A Guide to Living with Metastatic Disease. Sebastopol: O'Reilly and Associates, 1998.

Magrath, editor. The Non-Hodgkin's Lymphomas, 2nd edition. London: Arnold and Oxford University Press, 1997.

Nuland, Sherwin. How We Die: Reflections on Life's Final Chapter. New York: Alfred A. Knopf, 1993.

Ray, M. Catherine. I'm With You Now: A Guide Through Incurable Illness for Patients, Families, and Friends. New York: Bantam Books, 1997.

Weenolsen, Patricia. The Art of Dying. New York: St. Martin's Press, 1996.

Chapter 23: The Future of Therapy

Adjei AA, et al. Clinical Cancer Research 1998 Mar;4(3):683-691 "Effect of pyrazoloacridine (NSC 366140) on DNA topoisomerases I and II."

Aker M, et al. Journal of Pediatric Hematology and Oncology 1998 Mar;20(2):145-148 "Donor lymphocyte infusions to displace residual host hematopoietic cells after allogeneic bone marrow transplantation for beta-thalassemia major."

Anasetti C, et al. Transplantation 1992 Nov;54(5):844-851 "Treatment of acute graft-versus-host disease with a nonmitogenic anti-CD3 monoclonal antibody."

Ardalan B, et al. Cancer Investigation 1998;16(4):237-251 "Biomodulation of Fluorouracil in colorectal cancer."

Arguello F, et al. Blood 1998 Apr 1;91(7):2482-2490 "Flavopiridol induces apoptosis of normal lymphoid cells, causes immunosuppression, and has potent antitumor activity In vivo against human leukemia and lymphoma xenografts."

Bailly C, et al. Molecular Pharmacology 1998 Jan;53(1):77-87 "Recognition of specific sequences in DNA by a topoisomerase I inhibitor derived from the antitumor drug rebeccamycin."

Baer JC, et al. British Journal of Cancer 1993 Jun;67(6):1299-1302 "Depletion of O6-alkylguanine-DNA alkyltransferase correlates with potentiation of temozolomide and CCNU toxicity in human tumour cells."

Bantia S, et al. Immunopharmacology 1996 Oct;35(1):53-63 "In vivo and in vitro pharmacologic activity of the purine nucleoside phosphorylase inhibitor BCX-34: the role of GTP and dGTP."

Bear HD, et al. Anticancer Drugs 1996 May;7(3):299-306 "Bryostatin 1 activates splenic lymphocytes and induces sustained depletion of splenocyte protein kinase C activity in vivo after a single intravenous administration."

Benvenuto JA, et al. Biochemical Pharmacology 1995 Oct 12;50(8):1157-1164 Biochemical pharmacology of penclomedine (NSC-338720).

Bischoff JR, et al. Science V.274, Number 5286 18 October 1996, pp. 373 - 376 "An Adenovirus Mutant That Replicates Selectively in p53- Deficient Human Tumor Cells"

Brinkmann U Molecular Medicine Today 1996 Oct;2(10):439-446 "Recombinant immunotoxins: protein engineering for cancer therapy."

Cavalli LR, Varella-Garcia M, Liang BC Cell Growth and Differentiation 1997 Nov;8(11):1189-1198 "Diminished tumorigenic phenotype after depletion of mitochondrial DNA."

Clark AS, et al. Journal of Medical Chemistry 1995 Apr 28;38(9):1493-1504 "Antitumor imidazotetrazines. 32. Synthesis of novel imidazotetrazinones and related bicyclic heterocycles to probe the mode of action of the antitumor drug temozolomide."

Clinical Pharmacology Online: http://www.cponline.gsm.com

Dore BT, Chomienne C, Momparler RL Cancer Chemotherapy and Pharmacology 1998;41(4):275-280 "Effect of 5-aza-2'-deoxycytidine and vitamin D3 analogs on growth and differentiation of human myeloid leukemic cells."

Encell LP, Coates MM, Loeb LA Cancer Research 1998 Mar 1;58(5):1013-1020 "Engineering human DNA alkyltransferases for gene therapy using random sequence mutagenesis."

Farrell CL, et al. Cancer Research 1998 Mar 1;58(5):933-939 "Keratinocyte growth factor protects mice from chemotherapy and radiation-induced gastrointestinal injury and mortality."

Filippini C, et al. International Journal of Cancer 1997 Sep 4;72(5):801-809 "Hematopoietic toxicity and cell cycle perturbations induced by new DNA minor groove-alkylating agents."

Fodstad O, et al. Cancer Research 1985 Apr;45(4):1778-1786 "Activity of mitozolomide (NSC 353451), a new imidazotetrazine, against xenografts from human melanomas, sarcomas, and lung and colon carcinomas."

Giannelli Gianluigi, et al. Science Volume 277, Number 5323 Issue of 11 July 1997, pp. 225 - 228 "Induction of Cell Migration by Matrix Metalloprotease-2 Cleavage of Laminin-5"

Gould MN Environmental Health Perspectives 1997 Jun;105 Suppl 4:977-979 "Cancer chemoprevention and therapy by monoterpenes."

Hale G, et al. Blood 1998 Apr 15;91(8):3079-3083 "Risks of developing epstein-barr virus-related lymphoproliferative disorders after T-cell-depleted marrow transplants."

Helling F, et al. Cancer Research 1995 Jul 1;55(13):2783-2788 "GM2-KLH conjugate vaccine: increased immunogenicity in melanoma patients after administration with immunological adjuvant QS-21."

Huang Xianming, et al. Science V.275, Number 5299 Issue of 24 January 1997, pp. 547 - 550 "Tumor Infarction in Mice by Antibody-Directed Targeting of Tissue Factor to Tumor Vasculature"

Hudgins WR, et al. Biochemical Pharmacology 1996 Oct 25;52(8):1227-1233 "Transcriptional upregulation of gamma-globin by phenylbutyrate and analogous aromatic fatty acids."

Jang Meishiang, et al. Science V275, Number 5297 Issue of 10 January 1997, pp. 218 - 220 "Cancer Chemopreventive Activity of Resveratrol, a Natural Product Derived from Grapes"

Jones LA, et al. Journal of Medical Chemistry 1992 Jan;35(1):56-63 "Di- and triester prodrugs of the varicella-zoster antiviral agent 6-methoxypurine arabinoside."

Jones TR, et al. Journal of Medical Chemistry 1986 Jun;29(6):1114-1118 "Quinazoline antifolates inhibiting thymidylate synthase: variation of the amino acid."

Kees UR, Avramis VI Anticancer Drugs 1995 Apr;6(2):303-310 "Biochemical pharmacology and DNA methylation studies of arabinosyl 5-azacytidine and 5,6-dihydro-5-azacytidine in two human leukemia cell lines PER-145 and PER-163."

Keeling AA, Vaughan AT, Beaney RP British Journal of Cancer 1989 Jul;60(1):74-78 "Yttrium-90-EDTMP: a radiotherapeutic agent in the treatment of leukaemias."

Kiyokawa T, et al. Protein Engineering 1991 Apr;4(4):463-468 "Protein engineering of diphtheria-toxin-related interleukin-2 fusion toxins to increase cytotoxic potency for high-affinity IL-2-receptor-bearing target cells."

Kovar J, et al. Pathobiology 1997;65(2):61-68 "Direct evidence that iron deprivation induces apoptosis in murinelymphoma 38C13."

Kudoh S, Yamada M Gan To Kagaku Ryoho 1998 Jan;25(2):171-176 "Cytokine in cancer chemotherapy--clinical trials of IL-3, IL-11 and thrombopoietin against thrombocytopenia."

Levitsky HI, et al. Immunology 1996 May 15;156(10):3858-3865 "Immunization with granulocyte-macrophage colony-stimulating factor-transduced, but not B7-1-transduced, lymphoma cells primes idiotype-specific T cells and generates potent systemic antitumorimmunity."

Lim SH, et al. Bone Marrow Transplantation 1997 Jul;20(1):83-85 "Cyclosporin A/alpha interferon-induced autologous graft-versus-host disease following peripheral blood stem cell transplant for chronic myeloid leukaemia: a clinico-pathological study."

Losman MJ, et al. Cancer 1997 Dec 15;80(12 Suppl):2660-2666 "Generation of a high-producing clone of a humanized anti-B-cell lymphoma monoclonal antibody (hLL2)."

Lush RM, et al. Journal of Clinical Pharmacology 1997 Feb;37(2):123-128 "Initial pharmacokinetics and bioavailability of PSC 833, a P-glycoprotein antagonist."

Mangioni S, et al. Bone Marrow Transplantation 1997 Dec;20(11):969-973 "Long-term persistence of hemopoietic chimerism following sex-mismatched bone marrow transplantation."

Meijer L Progress in Cell Cycle Research 1995;1:351-363 "Chemical inhibitors of cyclin-dependent kinases."

Muller WE, et al. Chemical-Biological Interactions 1981 Mar 15;34(3):301-313 "Arabinosyl nucleosides. XXXII. Mechanism of inhibition of L5178y mouse lymphoma cells by 9-beta-D-arabinofuranosylguanine."

Murase N, et al. Transplantation 1997 Jun 27;63(12):1840-1843 "Effect in supralethally irradiated rats of granulocyte colony-stimulating factor and lisofylline on hematopoietic reconstitution by syngeneic bone marrow or whole organ passenger leukocytes."

Myohanen SK, Baylin SB, Herman JG Cancer Research 1998 Feb 15;58(4):591-593 "Hypermethylation can selectively silence individual p16ink4A alleles in neoplasia."

Nagoshi M, et al. Journal of Immunology 1998 Jan 1;160(1):334-344 "Successful adoptive cellular immunotherapy is dependent on induction of a host immune response triggered by cytokine (IFN-gamma and granulocyte/macrophage colony-stimulating factor) producing donor tumor-infiltrating lymphocytes."

The National Cancer Institute's clinical trial protocol database search engine at http://cancernet.nci.nih.gov

Nikolic B, Sykes M Current Opinions in Immunology 1997 Oct;9(5):634-640 "Bone marrow chimerism and transplantation tolerance."

Magrath, editor. The Non-Hodgkin's Lymphomas, 2nd edition. London: Arnold and Oxford University Press, 1997.

Ohno R, et al. Journal of Clinical Oncology 1990 Nov;8(11):1907-1912 "An early phase II study of CPT-11: a new derivative of camptothecin, for the treatment of leukemia and lymphoma."

Pan Guohua, et al. Science V277, Number 5327 8 August 1997, pp. 815 - 818 "An Antagonist Decoy Receptor and a Death Domain-Containing Receptor for TRAIL"

Parker BW, et al. Blood 1998 Jan 15;91(2):458-465 "Early induction of apoptosis in hematopoietic cell lines after exposure to flavopiridol."

Pizzoferrato E, et al. Human Gene Therapy 1997 Dec 10;8(18):2217-2228 "Enhanced immunogenicity of B cell lymphoma genetically engineered to express both B7-1 and interleukin-12."

Sackett DL Biochemistry 1995 May 30;34(21):7010-7019 "Vinca site agents induce structural changes in tubulin different from and antagonistic to changes induced by colchicine site agents."

Sandmaier BM, et al. Blood 1998 May 1;91(9):3494-3502 "Epitope specificity of CD44 for monoclonal antibody-dependent facilitation of marrow engraftment in a canine model."

Sharma HW, et al. Proceedings of the National Academy of Sciences U S A 1995 Dec 19;92(26):12343-12346 "Differentiation of immortal cells inhibits telomerase activity."

Sheridan, JP et al. Science V 277, Number 5327 8 August 1997, pp. 818 - 821 "Control of TRAIL-Induced Apoptosis by a Family of Signaling and Decoy Receptors."

Shiao RT, et al. Leukemia and Lymphoma 1996 Apr;21(3-4):293-303 "Mechanisms of inhibition of IL-6-mediated immunoglobulin secretion by dexamethasone and suramin in human lymphoid and myeloma cell lines."

Shizuru JA, et al. Biology of Blood and Marrow Transplantation 1996 Feb;2(1):3-14 "Transplantation of purified hematopoietic stem cells: requirements for overcoming the barriers of allogeneic engraftment."

Slavin S, et al. Blood 1998 Feb 1;91(3):756-763 "Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases."

Soiffer RJ, et al. Blood 1997 Apr 15;89(8):3039-3047 "CD6-depleted allogeneic bone marrow transplantation for acute leukemia in first complete remission."

Stayrook KR, et al. Carcinogenesis 1997 Aug;18(8):1655-1658 "Induction of the apoptosis-promoting protein Bak by perillyl alcohol in pancreatic ductal adenocarcinoma relative to untransformed ductal epithelial cells."

Stewart DJ, et al. Investigational New Drugs 1997;15(4):267-277 "Multiple resistance modulators combined with carboplatin for resistant malignancies: a pilot study."

Suresh KG, et al. Biochemistry 1997 Nov 18;36(46):14128-14136 "Mitomycin C-DNA adducts generated by DT-diaphorase. Revised mechanism of the enzymatic reductive activation of mitomycin C."

Svensson F, Mett H, Persson L Biochemistry Journal 1997 Feb 15;322( Pt 1):297-302 "CGP 48664, a potent and specific S-adenosylmethionine decarboxylase inhibitor: effects on regulation and stability of the enzyme."

Szende B, Zalatnai A, Schally AV Proceedings of the National Academy of Sciences U S A 1989 Mar;86(5):1643-1647 "Programmed cell death (apoptosis) in pancreatic cancers of hamsters after treatment with analogs of both luteinizing hormone-releasing hormone and somatostatin."

Takahashi M, et al. Journal of Antibiotics 1987 Jan;40(1):66-72 "Studies on macrocyclic lactone antibiotics. XI. Anti-mitotic and anti-tubulin activity of new antitumor antibiotics, rhizoxin and its homologues."

Takemura Y, et al. Japanese Journal of Cancer Research 1996 Jul;87(7):773-780 Biological activity and intracellular metabolism of ZD1694 in human leukemia cell lines with different resistance mechanisms to antifolatedrugs.

Twardowski P, Gradishar WJ Current Opinions in Oncology 1997 Nov;9(6):584-589 "Clinical trials of antiangiogenic agents."

van der Hem KG, et al. Leukemia Research 1996 Sep;20(9):743-750 "Heterogenous effects of bryostatin on human myeloid leukemia clonogenicity: dose and time scheduling dependency."

Wang Q, et al. Journal of the National Cancer Institute 1996 Jul 17;88(14):956-965 "UCN-01: a potent abrogator of G2 checkpoint function in cancer cells with disrupted p53."

Wiedemann GJ, et al. Anticancer Research 1997 Jul;17(4B):2899-2902 "Systemic hyperthermia and ICE chemotherapy for sarcoma patients: rationale and clinical status."

Witzig TE, et al. Journal of Clinical Oncology 1995 Aug;13(8):2012-2015 "Evaluation of a somatostatin analog in the treatment of lymphoproliferative disorders: results of a phase II North Central Cancer Treatment Group trial."

Woll PJ, et al. British Journal of Cancer 1995 Jul;72(1):183-184 "Phase II trial of temozolomide in low-grade non-Hodgkin's lymphoma."

Yamamoto T, Sudo K, Fujita T Anticancer Research 1994 Jan;14(1A):1-3 "Significant inhibition of endothelial cell growth in tumor vasculature by an angiogenesis inhibitor, TNP-470 (AGM-1470)."

Zajac P, et al. International Journal of Cancer 1997 May 2;71(3):491-496 "Generation of tumoricidal cytotoxic T lymphocytes from healthy donors after in vitro stimulation with a replication-incompetent vaccinia virus encoding MART-1/Melan-A 27-35 epitope."

Chapter 24: Researching Your Lymphoma

Hoffman, Barbara, editor. A Cancer Survivor's Almanac. The National Coalition for Cancer Survivorship. Minneapolis: Chronimed, 1996.

The Alpha Book on Cancer and Living. The Alpha Institute. Alameda, 1993.

Murphy, G., Morris, L., and Lange, D., editors. Informed Decisions - The Complete Book of Cancer Diagnosis, Treatment and Recovery. The American Cancer Society. New York: Viking Press, 1997.

Keene, Nancy. Working With Your Doctor: Getting the Healthcare You Deserve. Sebastopol: O'Reilly & Associates, 1998.

Motulsky, Harvey. Intuitive Biostatistics. New York: Oxford University Press, 1995.

The National Cancer Institute's web resources: http://cancernet.nci.nih.gov

Zakarian, Beverly. The Activist Cancer Patient. New York: John Wiley & Sons, 1996.


Patient Centers Home |  O'Reilly Home  |  Write for Us
How to Order  |  Contact Customer Service\

© 1999, O'Reilly & Associates, Inc.